OceanTech Acquisitions I Corp and Captura Biopharma Sign Definitive Business Combination Agreement
August 10, 2022
OceanTech Acquisitions I Corp., a special purpose acquisition company, signed a definitive merger agreement with Captura Biopharma to take the biotech company public. The combined company is expected to operate under the name Captura Biopharma Holdings, Inc. and remain listed on Nasdaq, subject to SEC, regulatory, and stockholder approvals.
- Buyers
- OceanTech Acquisitions I Corp.
- Targets
- Captura Biopharma, Inc.
- Industry
- Biotechnology
- Location
- United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Atlantic Coastal Acquisition Corp. II Completes Business Combination with Abpro Corporation
November 13, 2024
Biotechnology
Abpro Corporation and Atlantic Coastal Acquisition Corp. II completed their business combination and the combined company will operate as Abpro Holdings, Inc., with Abpro Corporation as a wholly owned subsidiary. The company is expected to begin trading on Nasdaq under the ticker ABP (and ABPWW for warrants); South Korea's Celltrion participated in a $5.0 million PIPE and appointed Soo Young Lee to Abpro's board.
-
SAB Biotherapeutics to Go Public via Merger with Big Cypress Acquisition Corp.
October 20, 2021
Biotechnology
SAB Biotherapeutics entered into a definitive business combination/merger agreement with Big Cypress Acquisition Corp. (a SPAC), with the combined company to operate as SAB Biotherapeutics and be listed on Nasdaq. Big Cypress stockholders approved the deal, and the transaction was expected to close on or about October 22, 2021, subject to customary conditions.
-
Investcorp Europe Acquisition Corp I and OpSec Group Business Combination to Take OpSec Public
April 26, 2023
Cybersecurity
OpSec Group and Investcorp Europe Acquisition Corp I entered into a definitive business combination agreement that would take OpSec Group public on Nasdaq. The combined company would operate as OpSec Group, with the transaction expected to close in the second half of 2023 and supported by a $50 million sponsor backstop and up to $199 million in gross proceeds subject to redemptions.
-
Voyager Acquisition Corp and VERAXA Biotech Announce Form F-4 Filing for Proposed Business Combination
July 17, 2025
Healthcare Services
VERAXA Biotech AG and Voyager Acquisition Corp. (a SPAC) have filed a Form F-4 registration statement with the SEC in connection with their proposed business combination announced in April 2025. Under the terms, VERAXA shareholders are expected to roll over 100% of their equity and receive approximately 130 million ordinary shares of the combined company, with the deal expected to close in Q4 2025.
-
Recochem Inc. Acquires Ocean Bio-Chem Holdings Inc. from OneWater Marine Inc.
February 10, 2026
Manufacturing
OneWater Marine Inc. completed the sale of Ocean Bio-Chem Holdings Inc. to Recochem Inc. for approximately $50 million in cash. OneWater plans to use proceeds to reduce debt and improve financial flexibility, with guidance updated to reflect the divestiture.
-
OneWater Marine Inc. Acquires Ocean Bio-Chem, Inc.
August 9, 2022
Consumer Products
OneWater Marine Inc. completed the acquisition of Ocean Bio-Chem, Inc., a manufacturer and distributor of appearance, cleaning, and maintenance products sold under brands such as Star brite. The deal strengthens OneWater's parts and accessories business and supports its strategy to expand market share and diversify revenue streams in the marine parts and accessories market.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.